Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Barcelona Institute of Science and Technology
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Barcelona Institute of Science and Technology (11)
2024
2023
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Cell Metabolism, Vol. 34, Núm. 6, pp. 857-873.e9
2021
-
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
Cell Metabolism, Vol. 33, Núm. 2, pp. 379-394.e8
2020
-
Epigenetic SmAd3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma
Cancer Research, Vol. 80, Núm. 2, pp. 276-290
-
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Cell, Vol. 181, Núm. 4, pp. 905-913.e7
2019
2017
-
NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma
Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981
2014
-
Heterogeneous micromechanical properties of the extracellular matrix in healthy and infarcted hearts
Acta Biomaterialia, Vol. 10, Núm. 7, pp. 3235-3242
2013
-
PrPC regulates epidermal growth factor receptor function and cell shape dynamics in Neuro2a cells
Journal of Neurochemistry, Vol. 127, Núm. 1, pp. 124-138